Loratadine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C22H23ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7AJO3BO7QN, chemically known as 1-piperidinecarboxylic acid, 4-(8-chloro-5,6-dihydro-11h-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-, ethyl ester but generally known as loratadine, which bears US NIH Compound Identifier 3957. European Medicines Agency schedules Loratadine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08581MIG. The term LORATADINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). World Health Organization schedules loratadine in its Anatomical Therapeutic Chemical (ATC) Classification. LORATADINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule loratadine under HS 29333999 and SITC 51574. As of Q4 2014, LORATADINE remains the US FDA Preferred Term for this commodity. Loratadine bears US NLM identifiers UMLS ID C0065180 and NCI Concept Code C29162. SMILES: CLC1CC2C(/C(=C3/CCN(CC3)C(=O)OCC)C3NCCCC3CC2)CC1.